Search

Displaying results 6231 - 6240 of 10000 in total
  1. Drug

    P-57AS3

    go.drugbank.com/drugs/DB06569
    Experimental

  2. Drug

    SPP1148

    go.drugbank.com/drugs/DB05203
    Experimental

    SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.

  3. Drug

    Enokizumab

    go.drugbank.com/drugs/DB05555
    Investigational

    A humanized immunoglobulin G1k anti-interleukin-9 mAb.

  4. Drug

    GW-559090

    go.drugbank.com/drugs/DB06508
    Experimental

  5. Drug

    Edaglitazone

    go.drugbank.com/drugs/DB06519
    Investigational

  6. Drug

    Tramiprosate

    go.drugbank.com/drugs/DB06527
    Investigational

  7. Drug

    Dextofisopam

    go.drugbank.com/drugs/DB06582
    Investigational

  8. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  9. Drug

    Amineptine

    go.drugbank.com/drugs/DB04836
    ApprovedIllicitWithdrawn

    The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until

  10. Drug

    Acoltremon

    go.drugbank.com/drugs/DB19202
    ApprovedInvestigational

    Acoltremon is under investigation in clinical trial NCT05493111 (A Long-term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512).

    Synonyms: N-(4-methoxyphenyl)-p-menthanecarboxamide, Cyclohexanecarboxamide, n-(4-methoxyphenyl)-5-methyl-2-(1-methylethyl)-, (1r,2s,5r)-